Edition:
United States

NeuroMetrix Inc (NURO.OQ)

NURO.OQ on NASDAQ Stock Exchange Capital Market

0.52USD
28 Apr 2017
Change (% chg)

$-0.03 (-4.63%)
Prev Close
$0.55
Open
$0.53
Day's High
$0.55
Day's Low
$0.50
Volume
20,687
Avg. Vol
39,864
52-wk High
$2.34
52-wk Low
$0.50

Latest Key Developments (Source: Significant Developments)

NeuroMetrix Q1 loss per share $0.91
Thursday, 20 Apr 2017 07:00am EDT 

April 20 (Reuters) - NeuroMetrix Inc :NeuroMetrix reports Q1 2017 financial results.Q1 revenue rose 89 percent to $4.3 million.Q1 loss per share $0.91.  Full Article

Neurometrix Q4 loss per share $0.52
Thursday, 26 Jan 2017 07:00am EST 

Neurometrix Inc : Neurometrix reports Q4 and full year 2016 financial results . Q4 revenue rose 36 percent to $3.7 million .Q4 loss per share $0.52.  Full Article

Neurometrix- in talks for partnerships for quell wearable pain relief technology
Tuesday, 16 Aug 2016 07:00am EDT 

Neurometrix Inc : Neurometrix commentary on strategic and business partnerships for quell wearable pain relief technology . Says is currently engaged in discussions around several types of partnerships including an e-commerce collaboration in US market .Also currently engaged in discussions around several types of partnerships for licensing, distribution rights to European, Asian markets, research and development.  Full Article

Neurometrix reports Q2 loss per share of $5.37
Thursday, 21 Jul 2016 07:00am EDT 

Neurometrix Inc : Neurometrix reports q2 2016 financial results and highlights . Neurometrix reports q2 2016 financial results and highlights . Q2 loss per share $5.37 . Q2 revenue rose 116 percent to $2.65 million .Q2 earnings per share view $-0.93, revenue view $2.7 million -- Thomson Reuters I/B/E/S.  Full Article

Neurometrix says expands DPNCheck commercialization in Mexico
Wednesday, 13 Jul 2016 07:00am EDT 

Neurometrix : Neurometrix expands DPNCheck commercialization in Mexico .Commercial expansion of DPNCheck in Mexico following receipt of a purchase order from one of Mexico's six major government healthcare institutions.  Full Article

Neurometrix says $21.3 mln private placement of preferred stock,warrants
Thursday, 2 Jun 2016 04:18pm EDT 

Neurometrix Inc: Neurometrix announces $21.3 million at the market private placement of preferred stock and warrants . Says private placement of 21,300 shares of series C convertible preferred stock at a price of $1,000 per share .Expected that about $13.8 million of proceeds of offering will be used to redeem 13,800 shares of series c convertible preferred stock.  Full Article

NeuroMetrix Inc announces distribution agreement with Prism Health Care Services
Tuesday, 27 Oct 2015 07:00am EDT 

NeuroMetrix Inc:Says agreement under which Prism will be the exclusive distributor of Quell wearable pain relief technology in Illinois and Wisconsin for patients in assisted and independent living centers.  Full Article

NeuroMetrix reports positive clinical study results for Quell(tm) Wearable Pain
Tuesday, 18 Aug 2015 07:00am EDT 

NeuroMetrix Inc:Announces preliminary results from a clinical study of the Quell Wearable Pain Relief device in subjects with chronic pain.  Full Article

NeuroMetrix, Inc Announces agreement with Advantage Consumer Healthcare to
Monday, 10 Aug 2015 12:29pm EDT 

NeuroMetrix, Inc:Says agreement with Advantage Consumer Healthcare to expand distribution of its Quell wearable pain relief technology into mass merchandisers, chain drug stores and other retail opportunities.  Full Article

NeuroMetrix Inc Prices Public Offering of $14.7 Million of Convertible Preferred Stock and Warrants
Wednesday, 27 May 2015 08:45am EDT 

NeuroMetrix, Inc:Says it has priced an upsized underwritten public offering of 147,000 units, with each unit consisting of one share of Series B convertible preferred stock and 99 warrants exercisable for 99 shares of our common stock, at a public offering price of $100 per unit.Says the gross proceeds to the company from this offering are estimated to be about $14.7 million.  Full Article

More From Around the Web

BRIEF-NeuroMetrix Q1 loss per share $0.91

* Q1 loss per share $0.91 Source text for Eikon: Further company coverage: